Prosecution Insights
Prosecution Insights
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 60.7% | +45.5% |
| COPPINS, JANET L | 1 | 72.9% | +25.5% |
| HABTE, KAHSAY | 1 | 85.1% | +7.3% |
| SZNAIDMAN, MARCOS L | 1 | 37.2% | +16.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18102268 | EXTENDED RELEASE 5-HT RECEPTOR AGONISTS FOR NEUROLOGICAL CONDITIONS | SZNAIDMAN, MARCOS L | 8d |
| 18501238 | 5-HT2A AND/OR 5-HT2C RECEPTOR AGONISTS | HABTE, KAHSAY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18102268 | EXTENDED RELEASE 5-HT RECEPTOR AGONISTS FOR NEUROLOGICAL CONDITIONS | SZNAIDMAN, MARCOS L | 8d |
| 19030518 | AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN | GONZALEZ, LUISALBERTO | — |
| 18813959 | COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION | COPPINS, JANET L | — |
| Art Unit | Apps |
|---|---|
| 1624 | 2 |
| 1628 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19030518 | AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN | GONZALEZ, LUISALBERTO | 1624 | §103 | Final Rejection | — | Pending | Jan 17, 2025 |
| 18813959 | COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION | COPPINS, JANET L | 1628 | §103 | Final Rejection | — | Pending | Aug 23, 2024 |
| 18501238 | 5-HT2A AND/OR 5-HT2C RECEPTOR AGONISTS | HABTE, KAHSAY | 1624 | §102§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18102268 | EXTENDED RELEASE 5-HT RECEPTOR AGONISTS FOR NEUROLOGICAL CONDITIONS | SZNAIDMAN, MARCOS L | 1628 | §102§103§112 | Non-Final OA | 8d | Pending | Jan 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial